Wakamoto Pharmaceutical Co.,Ltd.
TSE:4512.T
238 (JPY) • At close November 12, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) JPY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 7,738.426 | 8,660.377 | 8,383.144 | 8,894.837 | 10,917.899 | 10,741.975 | 10,900.874 | 10,833.025 | 11,194.262 | 10,613.425 | 10,314.297 | 9,924.168 | 9,429.946 | 9,671.815 | 9,779.708 | 10,081.276 | 10,181.164 |
Kosten van de omzet
| 4,197.578 | 4,552.316 | 4,027.25 | 4,407.168 | 4,723.967 | 4,623.281 | 4,816.041 | 4,974.168 | 4,916.446 | 4,775.123 | 4,710.779 | 4,617.393 | 4,348.319 | 4,494.712 | 4,096.646 | 3,853.311 | 3,547.063 |
Brutowinst
| 3,540.848 | 4,108.061 | 4,355.894 | 4,487.669 | 6,193.932 | 6,118.694 | 6,084.833 | 5,858.857 | 6,277.816 | 5,838.302 | 5,603.518 | 5,306.775 | 5,081.627 | 5,177.103 | 5,683.062 | 6,227.965 | 6,634.101 |
Brutowinstmarge
| 0.458 | 0.474 | 0.52 | 0.505 | 0.567 | 0.57 | 0.558 | 0.541 | 0.561 | 0.55 | 0.543 | 0.535 | 0.539 | 0.535 | 0.581 | 0.618 | 0.652 |
Onderzoek- en ontwikkelingskosten
| 513.313 | 580.454 | 593.958 | 641.514 | 1,725.588 | 1,607.424 | 1,378.17 | 1,141.703 | 1,301.224 | 0 | 0 | 0 | 0.792 | 0 | 0 | 0 | 0 |
Algemene en administratieve kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 6,158.325 | 0 | 0 | 0 | 0 | 0 | 3.423 | 0 | 0 | 0 | 0 |
Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.321 | 0 | 0 | 0 | 0 |
Verkoop-, algemene en administratieve kosten
| 3,223.046 | 3,326.784 | 3,775.323 | 4,538.901 | 5,397.209 | 4,833.137 | 6,158.325 | 4,557.08 | 4,824.747 | 0 | 0 | 0 | 4.744 | 0 | 0 | 0 | 0 |
Overige kosten
| 1.71 | 15.66 | 46.367 | 104.703 | 47.131 | -14.705 | -45.385 | 24.577 | 49.795 | 97.291 | 273.243 | 198.618 | 283.88 | 213.31 | 221.217 | 385.643 | 270.878 |
Bedrijfskosten
| 3,736.359 | 3,966.595 | 4,369.281 | 5,242.617 | 7,190.21 | 6,509.709 | 6,158.325 | 5,771.517 | 6,194.59 | 5,735.504 | 5,477.596 | 5,285.567 | 5,580.755 | 5,932.482 | 5,726.949 | 6,024.444 | 6,025.849 |
Bedrijfsresultaat
| -195.511 | 141.467 | -13.386 | -754.947 | -996.278 | -391.015 | -73.492 | 87.339 | 83.224 | 102.798 | 125.92 | 21.208 | -499.127 | -755.379 | -43.886 | 203.519 | 608.252 |
Bedrijfsresultaat ratio
| -0.025 | 0.016 | -0.002 | -0.085 | -0.091 | -0.036 | -0.007 | 0.008 | 0.007 | 0.01 | 0.012 | 0.002 | -0.053 | -0.078 | -0.004 | 0.02 | 0.06 |
Totaal overige inkomsten en kosten netto
| 354.365 | 70.107 | 298.244 | 51.941 | 85.236 | 161.216 | 247.661 | 82.648 | 42.819 | 128.87 | 1,232.851 | 427.382 | 371.642 | 128.555 | 184.885 | 403.851 | 109.007 |
Inkomen voor belasting
| 158.854 | 211.574 | 284.858 | -703.007 | -911.042 | -229.799 | 174.169 | 169.988 | 126.045 | 231.668 | 1,358.773 | 448.59 | -127.486 | -626.824 | 140.998 | 607.372 | 717.259 |
Inkomen voor belasting ratio
| 0.021 | 0.024 | 0.034 | -0.079 | -0.083 | -0.021 | 0.016 | 0.016 | 0.011 | 0.022 | 0.132 | 0.045 | -0.014 | -0.065 | 0.014 | 0.06 | 0.07 |
Belastingkosten
| 49.895 | 73.318 | 46.314 | -101.151 | 745.497 | -48.519 | 48.212 | 75.243 | 105.533 | 148.324 | 513.981 | 265.245 | 94.683 | -201.318 | 92.479 | 256.011 | 310.366 |
Nettowinst
| 108.959 | 138.256 | 238.543 | -601.856 | -1,656.539 | -181.28 | 125.956 | 94.745 | 20.512 | 83.343 | 844.791 | 183.344 | -222.17 | -425.505 | 48.518 | 351.361 | 406.893 |
Nettowinstmarge
| 0.014 | 0.016 | 0.028 | -0.068 | -0.152 | -0.017 | 0.012 | 0.009 | 0.002 | 0.008 | 0.082 | 0.018 | -0.024 | -0.044 | 0.005 | 0.035 | 0.04 |
WPA (Winst Per Aandeel)
| 3.14 | 3.98 | 6.87 | -17.34 | -47.73 | -5.22 | 3.63 | 2.73 | 0.59 | 2.4 | 24.3 | 5.27 | -6.38 | -12.3 | 1.41 | 10.2 | 12 |
Verwaterde WPA
| 3.14 | 3.98 | 6.87 | -17.34 | -47.73 | -5.22 | 3.63 | 2.73 | 0.59 | 2.4 | 24.3 | 5.27 | -6.38 | -12.3 | 1.41 | 10.2 | 12 |
EBITDA
| 149.944 | 649.096 | 547.983 | -120.078 | -438.216 | 105.495 | 452.944 | 767.921 | 880.881 | 1,015.26 | 1,106.832 | 1,007.94 | 793.637 | 663.81 | 900.464 | 756.933 | 1,294.462 |
EBITDA ratio
| 0.019 | 0.075 | 0.065 | -0.013 | -0.04 | 0.01 | 0.042 | 0.071 | 0.079 | 0.096 | 0.107 | 0.102 | 0.084 | 0.069 | 0.092 | 0.075 | 0.127 |